Oscar Health (NYSE:OSCR) Director Mario Schlosser Sells 150,000 Shares

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 150,000 shares of the firm’s stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $30.79, for a total transaction of $4,618,500.00. Following the completion of the sale, the director owned 480,866 shares in the company, valued at $14,805,864.14. This represents a 23.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Mario Schlosser also recently made the following trade(s):

• On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The stock was sold at an average price of $30.34, for a total value of $18,204,000.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total transaction of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total value of $25,854,400.00.
• On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total value of $748,592.80.

Oscar Health Stock Performance

NYSE:OSCR opened at $30.00 on Tuesday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. Oscar Health, Inc. has a fifty-two week low of $10.69 and a fifty-two week high of $33.55. The company has a 50 day simple moving average of $30.30 and a two-hundred day simple moving average of $22.25. The company has a market capitalization of $9.26 billion, a PE ratio of 21.43, a P/E/G ratio of 0.63 and a beta of 2.36.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.70. The firm had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.73 billion. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business’s quarterly revenue was up 70.4% on a year-over-year basis. During the same period last year, the company posted ($0.89) EPS. Research analysts anticipate that Oscar Health, Inc. will post 1.54 earnings per share for the current year.

Analyst Upgrades and Downgrades

OSCR has been the topic of several recent research reports. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Monday, July 6th. Robert W. Baird set a $27.00 price objective on Oscar Health in a report on Friday, August 7th. Wall Street Zen raised Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Wolfe Research began coverage on Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating on the stock. Finally, Weiss Ratings raised shares of Oscar Health from a “sell (d+)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, Oscar Health has an average rating of “Hold” and an average price target of $26.22.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its holdings in Oscar Health by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after buying an additional 540,851 shares in the last quarter. Geode Capital Management LLC lifted its stake in Oscar Health by 2.5% during the 4th quarter. Geode Capital Management LLC now owns 4,798,313 shares of the company’s stock valued at $68,964,000 after acquiring an additional 116,430 shares in the last quarter. BIT Capital GmbH lifted its stake in Oscar Health by 545.0% during the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after acquiring an additional 5,227,152 shares in the last quarter. Simplify Asset Management Inc. purchased a new position in Oscar Health during the 4th quarter worth $2,948,000. Finally, Fortis Group Advisors LLC grew its stake in shares of Oscar Health by 82.9% in the 4th quarter. Fortis Group Advisors LLC now owns 189,857 shares of the company’s stock worth $2,724,000 after acquiring an additional 86,035 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.